BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27666488)

  • 1. MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma.
    Olbromski M; Grzegrzolka J; Jankowska-Konsur A; Witkiewicz W; Podhorska-Okolow M; Dziegiel P
    Oncol Rep; 2016 Nov; 36(5):2884-2892. PubMed ID: 27666488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.
    Olbromski M; Rzechonek A; Grzegrzolka J; Glatzel-Plucinska N; Chachaj A; Werynska B; Podhorska-Okolow M; Dziegiel P
    Oncol Rep; 2018 Jan; 39(1):201-208. PubMed ID: 29115529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of SOX18 expression in non-small cell lung cancer.
    Jethon A; Pula B; Olbromski M; Werynska B; Muszczynska-Bernhard B; Witkiewicz W; Dziegiel P; Podhorska-Okolow M
    Int J Oncol; 2015 Jan; 46(1):123-32. PubMed ID: 25310193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
    Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
    Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
    Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
    Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
    Shen Y; Pan X; Yang J
    J Cell Physiol; 2019 Dec; 234(12):22896-22910. PubMed ID: 31169310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SOX18 Transcription Factor Activity by Small-Molecule Inhibitor Sm4 in Non-Small Lung Cancer Cell Lines.
    Rodak O; Mrozowska M; Rusak A; Gomułkiewicz A; Piotrowska A; Olbromski M; Podhorska-Okołów M; Ugorski M; Dzięgiel P
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival.
    Zhang J; Zhu N; Chen X
    Tumour Biol; 2015 Sep; 36(10):7465-71. PubMed ID: 25908174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
    Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
    Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX18 expression predicts response to platinum-based chemotherapy in ovarian cancer.
    Pula B; Kobierzycki C; Solinski D; Olbromski M; Nowak-Markwitz E; Spaczynski M; Kedzia W; Zabel M; Dziegiel P
    Anticancer Res; 2014 Aug; 34(8):4029-37. PubMed ID: 25075026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of SOX18 by siRNA inhibits cell growth and invasion of breast cancer cells.
    Zhang J; Ma Y; Wang S; Chen F; Gu Y
    Oncol Rep; 2016 Jun; 35(6):3721-7. PubMed ID: 27108946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX18 Expression in Non-melanoma Skin Cancer.
    Ornat M; Kobierzycki C; Grzegrzolka J; Pula B; Zamirska A; Bieniek A; Szepietowski JC; Dziegiel P; Okolow MP
    Anticancer Res; 2016 May; 36(5):2379-83. PubMed ID: 27127146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC.
    Li X; Wang HL; Peng X; Zhou HF; Wang X
    Biochem Biophys Res Commun; 2012 Oct; 427(2):254-60. PubMed ID: 22995297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.
    Eide HA; Halvorsen AR; Bjaanæs MM; Piri H; Holm R; Solberg S; Jørgensen L; Brustugun OT; Kiserud CE; Helland Å
    BMC Cancer; 2016 Feb; 16():71. PubMed ID: 26858029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.